A study by researchers at Columbia University Vagelos College of Physicians and Surgeons has found that new cutting-edge ...

Prime editing holds tremendous promise for precise genome engineering, but achieving efficient editing without increasing pegRNA complexity remains a significant challenge. Join this webinar to ...

Treating inherited diseases is one of the greatest challenges in modern medicine. In the future, targeted gene corrections at ...

Cellectis is shifting its development strategy toward in vivo gene editing after reporting preclinical proof-of-concept for ...

Editas Medicine reports advancements in in vivo gene editing, financial results, and plans for upcoming development candidates by mid-2025. Editas Medicine, Inc. announced its progress in developing ...

mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved product Company expects supply to be available ... · ACCESS Newswire · Moderna, Inc. The above button links to ...

ProWritingAid has introduced its Manuscript Analysis tool, a feature specifically designed to assist authors in enhancing their manuscripts through developmental editing. This innovative tool focuses ...

Shares of Editas Medicine EDIT plunged 12.5% on Tuesday after announcing that it is seeking a global partner to advance its lead gene editing therapy, reni-cel, which is being developed for certain ...